Bullish Case: CDRE has fallen ~30% year-over-year to $25.47 while backlog, defense/nuclear demand, and the historical return surface still cluster modest positive returns for short holds. Helium odds (~0.20 vs market ~0.196 at low strikes) tilt slightly less bearish than market pricing, and 01/15/27 30C/35C call open interest implies recovery optionality toward $30–35 if Q4 execution stabilizes margins.

Bearish Case: Momentum is firmly negative (-13% in 90 days, -14% in a month), the term structure remains in backwardation, and near-dated put IV is extreme (10/16 15P ~352%, 17.5P ~281%), signaling real idiosyncratic execution/liquidity risk. The Helium and market densities both peak in the $20–25 band, below spot, implying further downside is the modal path.

Potential Outcomes:

1. 45% Drift to $20–24 by Jan 15 — densities (Helium: 0.179 at 20, 0.181 at 22.5 vs 0.167 at 17.5) put the distribution's center below spot; test: close <$24 by Nov 20.
2. 25% Stabilize $25–28; backwardation eases; test: holds $25 with falling put IV.
3. 15% Break below $20; margin/delivery shock; test: <$20 with 15P IV >150%.
4. 10% Recovery $28–32 on contract news; test: close >$28 by Dec.
5. 5% >$35 breakout; test: 35C IV collapse + spot >$32.

Prior mean-reversion calls ($38–42, $34–38) repeatedly missed; I've shifted weight to the options-implied distribution, which has been the more accurate guide.

September 30, 2026